1French N,Gray K,Watera C,et al.Cryptococcal infection in a cohort of HIV-1 infected Ugandan adults[J].AIDS,2002,16(7):1031-1038.
2Bicanic T,Harrison TS,Cryptococcal meningitis[J].Br Med Bull,2005,72(1):99-118.
3Satishchandra P,Mathew T,Gadre G,et al.Cryptococcal meningitis:Clinical,diagnostic and therapeutic overviews[J].Neurol India,2007,55(3):226-232.
4Perfect JR,Casadevall A.Cryptococcosis[J].Infect Dis Clin North Am,2002,16(4):837-874.
5Crowe SM,Carlin JB,Stewart KI,et al.Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons[J].J Acquir Immune Defic Syndr,1991,4(8):770-776.
5Ehmann WC, EysterME, Wilson SE, et al. Relationship of CD4 Lym2phocyte counts to survival in a cohort of hemophiliacs infected withHIV. Multicenter Hemophilia Cohort Study [J]. J Acquir Immtme DeficSyndr, 1994, 7 (10) : 1095 - 1098.
6Michad S. Saag, Richard J, et al. Practice guidelines for the management of oryptococcal disease [ J ]. Clin Infect Dis, 2000,30:710- 718.
7Mussini C, Pezzotti P, Miro JM, et al. Discontinuation of maintenancetherapy for cryptocoecal meningitis in patients with AIDStreated with highly active antiretroviral therapy: an internationalobservational study[ J ]. Clin Infect Dis, 2004 Feb 15, 38: 565 - 571.
